<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Somatic activation of a conditional targeted Kras(G12D) allele induces a fatal <z:mpath ids='MPATH_512'>myeloproliferative disease</z:mpath> in mice that closely models juvenile and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>These mice consistently develop severe and progressive <z:hpo ids='HP_0001903'>anemia</z:hpo> despite adequate numbers of clonogenic erythroid progenitors in the bone marrow and expanded splenic hematopoiesis </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0010972'>Ineffective erythropoiesis</z:hpo> is characterized by impaired differentiation </plain></SENT>
<SENT sid="3" pm="."><plain>These results demonstrate that endogenous levels of oncogenic Ras have cell lineage-specific effects and support efforts to modulate Ras signaling for therapy of <z:hpo ids='HP_0001903'>anemia</z:hpo> in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> </plain></SENT>
</text></document>